Next Article in Journal
Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications
Next Article in Special Issue
Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent
Previous Article in Journal
Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity
Previous Article in Special Issue
The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 30 April 2019 14:20 CEST Original file -
article pdf uploaded. 30 April 2019 14:20 CEST Version of Record https://www.mdpi.com/2073-4409/8/5/402/pdf-vor
article xml file uploaded 1 May 2019 05:49 CEST Update -
article xml uploaded. 1 May 2019 05:49 CEST Update https://www.mdpi.com/2073-4409/8/5/402/xml
article pdf uploaded. 1 May 2019 05:49 CEST Updated version of record https://www.mdpi.com/2073-4409/8/5/402/pdf
article supplementary file uploaded. 1 May 2019 05:49 CEST - https://www.mdpi.com/2073-4409/8/5/402#supplementary
article html file updated 1 May 2019 05:51 CEST Original file -
article html file updated 4 June 2019 22:37 CEST Update -
article html file updated 19 October 2019 07:43 CEST Update -
article html file updated 12 February 2020 09:00 CET Update https://www.mdpi.com/2073-4409/8/5/402/html
Back to TopTop